Form 4: Ventyx Biosciences Senior VP Acquires Shares

Ventyx Biosciences' Senior VP of Finance, Roy Gonzales, acquired 1,767 shares of common stock through the company's Employee Stock Purchase Plan at a discounted price.

Summary

• Roy Gonzales, Senior VP of Finance at Ventyx Biosciences, Inc. (VTYX), acquired 1,767 shares of common stock.
• The transaction occurred on November 17, 2025.
• Shares were purchased at a price of $1.03 per share.
• The acquisition was made pursuant to the Ventyx Biosciences, Inc. 2021 Employee Stock Purchase Plan ("2021 ESPP").
• The purchase price of $1.03 was based on 85% of the closing price on May 15, 2025, in accordance with the ESPP terms.
• Following this transaction, Roy Gonzales beneficially owns 5,313 shares of common stock directly.
• The transaction is exempt under Rule 16b-3(c).

Sentiment

Score: 7

Explanation: The acquisition of shares by a senior executive, even through a routine ESPP, generally indicates a degree of confidence in the company's future. While not a large open-market purchase, it's a positive signal of alignment between management and shareholder interests.

Positives

• An insider, the Senior VP of Finance, acquired additional shares, which can signal confidence in the company's future prospects.
• The acquisition was made at a discounted price of $1.03 per share, reflecting a benefit to the employee through the ESPP.
• The transaction was part of a pre-arranged Employee Stock Purchase Plan, indicating a structured and routine acquisition.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Employee Stock Purchase Plans (ESPPs) are common mechanisms in publicly traded companies, particularly in the biotechnology sector like Ventyx Biosciences, to incentivize and retain employees by allowing them to purchase company stock, often at a discount. Such plans align employee interests with shareholder interests.

Comparison to Industry Standards

• Employee Stock Purchase Plans (ESPPs) are a standard component of compensation packages across various industries, including biotechnology.
• The discount offered (implied 15% off the May 15, 2025 closing price) is typical for ESPPs, which often range from 5% to 15%.
• The acquisition by a Senior VP of Finance through an ESPP is a routine event and aligns with common corporate practices for employee equity participation.

Stakeholder Impact

• Shareholders: Potentially a minor positive signal of management confidence in the company's value.
• Employees: Reinforces the benefit of the company's Employee Stock Purchase Plan.

Key Dates

Keywords

Ventyx Biosciences, VTYX, Roy Gonzales, insider transaction, Form 4, stock purchase, ESPP, employee stock plan, common stock, beneficial ownership